8-K: Current report
Apr 26 04:38
8-K: Current report
Apr 18 04:37
ZyVersa Therapeutics | DEFA14A: Others
Mar 28 05:05
ZyVersa Therapeutics | 10-K: Annual report
Mar 25 20:03
ZyVersa Therapeutics | DEF 14A: Definitive information statements
Mar 20 05:29
ZyVersa Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 9 06:02
ZyVersa Therapeutics | 8-K: Current report
Mar 9 06:02
ZyVersa Therapeutics | 8-K: Current report
Mar 2 05:36
ZyVersa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ionic Ventures, LLC(4.0%),Ionic Management, LLC(4.0%), etc.
Feb 15 07:13
ZyVersa Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 15 05:43
ZyVersa Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Anson Funds Management LP(9.8%),Anson Management GP LLC(9.8%), etc.
Feb 15 05:21
ZyVersa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-L1 Capital Global Opportunities Master Fund Ltd.(0%)
Feb 10 05:06
ZyVersa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-INCON Co., Ltd.(3.44%)
Jan 19 13:00
ZyVersa Therapeutics | 8-K: Current report
Dec 23, 2023 05:45
ZyVersa Therapeutics | 8-K: Current report
Dec 12, 2023 05:30
ZyVersa Therapeutics | 424B4: Prospectus
Dec 9, 2023 05:44
ZyVersa Therapeutics | EFFECT: Others
Dec 7, 2023 13:15
ZyVersa Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Dec 7, 2023 05:13
ZyVersa Therapeutics | CORRESP: CORRESP
Dec 6, 2023 13:00
ZyVersa Therapeutics | CORRESP: CORRESP
Dec 6, 2023 13:00
No Data
No Data